Antibiotic Resistant Infection Clinical Trials

62 clinical trials for Antibiotic Resistant Infection across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement. — RECRUITING · PHASE2
• Interventions to Decrease CRE Colonization and Transmission Between Hospitals, Households, Communities and Domesticated Animals — RECRUITING · NA
• Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates — RECRUITING · NA
• Post-Operative Antibiotic Efficacy in Clean Contaminated Head and Neck Surgery: A Randomized Controlled Trial — RECRUITING · NA
• Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery — RECRUITING · PHASE3
• The Role of Postoperative Antibiotics in Laparoscopic Cholecystectomy — RECRUITING · PHASE4
• Helicobacter Pylori Local Prevalence and Antibiotic Resistance — RECRUITING
• Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs — RECRUITING · PHASE3
• Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea — TERMINATED · PHASE3
• Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation — WITHDRAWN · PHASE2
• ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT — COMPLETED
• Bolus Versus Continuous Infusion of Meropenem — COMPLETED · PHASE4
• Inulin for Infections in the Intensive Care Unit — COMPLETED · PHASE2
• Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK) — COMPLETED
• CD64 and Antibiotics in Human Sepsis — COMPLETED
• Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections — WITHDRAWN · PHASE4
• Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI) — COMPLETED · NA
• The Antibiotic Guardian Study- Clinical Evaluation of a Novel, Rapid Diagnostic for Gonorrhoea and Mycoplasma Infections. — COMPLETED
• Optimal Tailored Treatment for H. Pylori Infection — WITHDRAWN · NA
• Optimized Perioperative Antibiotic Prophylaxis in Radical Cystectomy — COMPLETED · NA
• Antibiotic Use and Resistance KAP Among Dental Interns — OTHER
• Cholecystitis From a Microbiological and Histopathological Perspective — OTHER
• Opportunities for Antibiotic Optimisation and Outcomes Improvement in Patients With Negative Blood Culture (NO-BACT) — COMPLETED · NA
• Prosthesis Infection and One-step Exchange: Pretreatment by Targeted Antibiotic Therapy in At-risk Patients — COMPLETED
• Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients — OTHER
• Pharmacokinetics of High-dose Tigecycline in Critically Ill Patients — COMPLETED
• Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment — NOT_YET_RECRUITING
• Evaluation of the Impact of the Modification of Antibiotic Susceptibility Testing on Antibiotic Prescriptions — OTHER
• Probiotics and Multi-Drug Resistant Urinary Tract Infection — COMPLETED · NA
• Postoperative Antibiotics Following Primary and Secondary Breast Augmentation — WITHDRAWN · PHASE4
• Antibiotic Resistance in Global Pediatric Oncology Centers — COMPLETED
• Modified Surface of PLGA Nanoparticles in Smart Hydrogel — COMPLETED · PHASE1
• Complications After Lower Third Molar Surgery — OTHER · NA
• The Impact of Covid-19 Hospital Care on the Prevalence of MDRO in Indonesia — OTHER
• Phenotypic Profile and Molecular Mechanism of Resistance in Carbapenemase-producing Enterobacterales and Pseudomonas Aeruginosa Isolates From Brazilian Hospitals: Implications for the Introduction of IMIPENEM-RELEBACTAM — OTHER
• Clinical/Microbiological Impact of a Specific Antimicrobial Stewardship Program for Nursing Homes — COMPLETED · NA
• Comprehensive Molecular Diagnosis and Management of Hospital- and Ventilator-associated Pneumonia in Norway — OTHER
• Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan — COMPLETED
• Effect of Antibiotics on Urinary Microbiome — WITHDRAWN · PHASE1
• Enhanced, Personalized and Integrated Care for Infection Management at the Point-Of-Care — COMPLETED
• Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. — OTHER · PHASE3
• Assessing the Impact of Antimicrobial Exposure and Infection Control Measures on the Spread of VRE — OTHER
• Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit — COMPLETED
• Establish the Relationship Between Shift in Prescribing Pattern and Associated Shift in Sensitivity Pattern of Causative Microbes in UTI Patients in a Closed Community — COMPLETED · PHASE4
• Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study. — OTHER
• Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB) — COMPLETED · NA
• Antibiotic Stewardship Program in Pancreatic Surgery: a Multicenter Time Series Analysis (BIOSTEPS). — OTHER
• Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI) — COMPLETED · PHASE4
• ESBL in Patients Returning to Sweden With Traveller's Diarrhoea — COMPLETED
• Strategy to Prevent Transmission of Multidrug-resistant Gram-negative Organisms in ICU — OTHER · NA

Refine this search